Evidence for the pathophysiological relevance of TRPA1 receptors in the cardiovascular system in vivo

Cardiovasc Res. 2010 Sep 1;87(4):760-8. doi: 10.1093/cvr/cvq118. Epub 2010 May 3.

Abstract

Aims: The aim of the study is to investigate transient receptor potential ankyrin 1 (TRPA1)-induced responses in the vasculature and on blood pressure and heart rate (HR), in response to TRPA1 agonists using wild-type (WT) and TRPA1 knockout (KO) mice.

Methods and results: TRPA1 agonists allyl isothiocyanate and cinnamaldehyde (CA) significantly increased blood flow in the skin of anaesthetized WT, but not in TRPA1 KO mice. CA also induced TRPA1-dependent relaxation of mesenteric arteries. Intravenously injected CA induced a transient hypotensive response accompanied by decreased HR that was, depending on genotype and dose, followed by a more sustained dose-dependent pressor response (10-320 micromol/kg). CA (80 micromol/kg) induced a depressor response that was significantly less in TRPA1 KO mice, with minimal pressor effects. The pressor response of a higher CA dose (320 micromol/kg) was observed in WT but not in TRPA1 KO mice, indicating involvement of TRPA1. Experiments using TRP vanilloid 1 (TRPV1) KO and calcitonin gene-related peptide (CGRP) KO mice provided little evidence for the involvement of TRPV1 or CGRP, nor did blocking substance P receptors affect responses. However, the cholinergic antagonist atropine sulphate (5 mg/kg) significantly inhibited the depressor response and slowed HR with CA (80 micromol/kg), but had no effect on pressor responses. The pressor response remained unaffected, even in the presence of the ganglion blocker hexamethonium bromide (1 mg/kg). The alpha-adrenergic blocker prazosin hydrochloride (1 mg/kg) significantly inhibited both components, but not slowed HR.

Conclusion: TRPA1 is involved in mediating vasodilation. TRPA1 can also influence changes in blood pressure of possible relevance to autonomic system reflexes and potentially to vasovagal/neurocardiogenic syncope disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acrolein / analogs & derivatives
  • Acrolein / pharmacology
  • Adrenergic alpha-1 Receptor Antagonists / pharmacology
  • Animals
  • Atropine / pharmacology
  • Blood Pressure
  • Calcitonin Gene-Related Peptide / genetics
  • Calcitonin Gene-Related Peptide / metabolism
  • Dose-Response Relationship, Drug
  • Female
  • Ganglionic Blockers / pharmacology
  • Heart Rate
  • Hemodynamics* / drug effects
  • Hexamethonium / pharmacology
  • Isothiocyanates / pharmacology
  • Male
  • Mesenteric Arteries / drug effects
  • Mesenteric Arteries / metabolism*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Microcirculation* / drug effects
  • Muscarinic Antagonists / pharmacology
  • Prazosin / pharmacology
  • Regional Blood Flow
  • Skin / blood supply*
  • Substance P / metabolism
  • TRPA1 Cation Channel
  • Time Factors
  • Transient Receptor Potential Channels / agonists
  • Transient Receptor Potential Channels / deficiency
  • Transient Receptor Potential Channels / genetics
  • Transient Receptor Potential Channels / metabolism*
  • Vasodilation

Substances

  • Adrenergic alpha-1 Receptor Antagonists
  • Ganglionic Blockers
  • Isothiocyanates
  • Muscarinic Antagonists
  • TRPA1 Cation Channel
  • Transient Receptor Potential Channels
  • Trpa1 protein, mouse
  • Substance P
  • Hexamethonium
  • Acrolein
  • Atropine
  • allyl isothiocyanate
  • Calcitonin Gene-Related Peptide
  • cinnamaldehyde
  • Prazosin